NovoCure Gets FDA Approval for Cancer Treatment
NovoCure, which is backed by WFD Ventures, has been granted approval by the FDA to markets its treatment for glioblastoma multiforme.
18 April 2011•2 mins read
NovoCure, which is backed by WFD Ventures, has been granted approval by the FDA to markets its treatment for glioblastoma multiforme.
